Robert Shafer

Robert Shafer

Stanford University

H-index: 92

North America-United States

About Robert Shafer

Robert Shafer, With an exceptional h-index of 92 and a recent h-index of 45 (since 2020), a distinguished researcher at Stanford University, specializes in the field of HIV Drug Resistance.

His recent articles reflect a diverse array of research interests and contributions to the field:

GPT-4 Performance on Querying Scientific Publications: Reproducibility, Accuracy, and Impact of an Instruction Sheet

Risk of Emergent Dolutegravir Resistance Mutations In People Living With HIV: A Rapid Scoping Review

Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use

The use of nirmatrelvir-ritonavir in a case of breakthrough long COVID

Update History

Recommendations on data sharing in HIV drug resistance research

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19

Robert Shafer Information

University

Position

Professor of Medicine

Citations(all)

31239

Citations(since 2020)

8082

Cited By

25899

hIndex(all)

92

hIndex(since 2020)

45

i10Index(all)

237

i10Index(since 2020)

124

Email

University Profile Page

Stanford University

Google Scholar

View Google Scholar Profile

Robert Shafer Skills & Research Interests

HIV Drug Resistance

Top articles of Robert Shafer

Title

Journal

Author(s)

Publication Date

GPT-4 Performance on Querying Scientific Publications: Reproducibility, Accuracy, and Impact of an Instruction Sheet

Kaiming Tao

Zachary A Osman

Philip L Tzou

Soo-Yon Rhee

Vineet Ahluwalia

...

2024/1/12

Risk of Emergent Dolutegravir Resistance Mutations In People Living With HIV: A Rapid Scoping Review

Carolyn Chu

Kaiming Tao

Vinie Kouamou

Ava Avalos

Jake Scott

...

2024

Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review

Carolyn Chu

Kaiming Tao

Vinie Kouamou

Ava Avalos

Jake Scott

...

2024/3/4

Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use

Lawrence Mbuagbaw

Cristian Garcia

Bluma Brenner

Diego Cecchini

Mohamed Chakroun

...

2023/10/1

The use of nirmatrelvir-ritonavir in a case of breakthrough long COVID

Exploratory Research and Hypothesis in Medicine

Linda N Geng

Hector F Bonilla

Robert W Shafer

Mitchell G Miglis

Phillip C Yang

2023/12/25

Update History

Update

Adarsh Bhimraj

Rebecca L Morgan

Amy Hirsch Shumaker

Lindsey Baden

Vincent Chi-Chung Cheng

...

2023/4/11

Recommendations on data sharing in HIV drug resistance research

PLoS medicine

Seth C Inzaule

Mark J Siedner

Susan J Little

Santiago Avila-Rios

Alisen Ayitewala

...

2023/9/22

Low-dose naltrexone use for the management of post-acute sequelae of COVID-19

Hector Bonilla

Lu Tian

Vincent Marconi

Robert William Shafer

Grace Mccomsey

...

2023

Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

The Lancet HIV

Jennifer Smith

Loveleen Bansi-Matharu

Valentina Cambiano

Dobromir Dimitrov

Anna Bershteyn

...

2023/4/1

HIV drug resistance

Fundamentals of HIV Medicine 2023

Carolyn Chu

Lealah Pollock

Robert W Shafer

2023/10/24

HIV-1 5’-Leader Mutations in Plasma Viruses Before and After the Development of Reverse Transcriptase Inhibitor-Resistance Mutations

medRxiv

Janin Nouhin

Philip L Tzou

Soo-Yon Rhee

Malaya K Sahoo

Benjamin A Pinsky

...

2023/6/5

Highly Ambiguous HIV-1 Pol Positions Encoding Multiple Amino Acids Usually Result from Antiviral or Immune Selection Pressure

AIDS Research and Human Retroviruses

Kaiming Tao

Soo-Yon Rhee

Philip L Tzou

Susan P Holmes

Robert W Shafer

2023/3/1

Treatment emergent Dolutegravir resistance mutations in individuals naïve to HIV-1 integrase inhibitors: A rapid scoping review

Kaiming Tao

Soo-Yon Rhee

Carolyn Chu

Ava Avalos

Amrit K Ahluwalia

...

2023/9/15

Human immunodeficiency virus 1 5′-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutations

Journal of General Virology

Janin Nouhin

Philip Lei Tzou

Soo-Yon Rhee

Malaya K Sahoo

Benjamin A Pinsky

...

2023/10/6

HIV-1 Group M Capsid Amino Acid Variability: Implications for Sequence Quality Control of Genotypic Resistance Testing

Viruses

Kaiming Tao

Soo-Yon Rhee

Philip L Tzou

Zachary A Osman

Sergei L Kosakovsky Pond

...

2023/4/18

Potential role of doravirine for the treatment of HIV-1-infected persons with transmitted drug resistance

AIDS Research and Therapy

Soo-Yon Rhee

Jonathan M Schapiro

Francesco Saladini

Maurizio Zazzi

Saye Khoo

...

2023/2/7

Selection analysis identifies unusual clustered mutational changes in Omicron lineage BA. 1 that likely impact Spike function

BioRxiv

Darren P Martin

Spyros Lytras

Alexander G Lucaci

Wolfgang Maier

Björn Grüning

...

2022/1/18

Selection analysis identifies clusters of unusual mutational changes in Omicron lineage BA. 1 that likely impact Spike function

Molecular Biology and Evolution

Darren P Martin

Spyros Lytras

Alexander G Lucaci

Wolfgang Maier

Björn Grüning

...

2022/4/1

Genotypic correlates of resistance to the HIV-1 strand transfer integrase inhibitor cabotegravir

Antiviral Research

Soo-Yon Rhee

Neil Parkin

P Richard Harrigan

Susan Holmes

Robert W Shafer

2022/12/1

Case report of breakthrough long COVID and the use of nirmatrelvir-ritonavir

Linda N Geng

Hector F Bonilla

Robert W Shafer

Mitchell G Miglis

Phillip C Yang

2022/3/15

See List of Professors in Robert Shafer University(Stanford University)